🚨 URGENT: NC Medicaid Coverage for AOMs at Risk!
NC Residents, Health Advocates, and Media– Take Notice
Help Us Maintain NC Medicaid Coverage for Obesity Medications!
Currently, a budget bill is making its way through the North Carolina General Assembly that would eliminate Medicaid coverage for obesity medications.
This isn’t about cosmetic weight loss— it’s about treating obesity as a serious medical disease. These medications help manage chronic conditions like heart disease, diabetes, and kidney failure, and they're proven to reduce heart attacks, strokes, and long-term healthcare costs.
Over 1 in 3 North Carolinians live with obesity.
These medications are standard of care— not luxury drugs.
Cutting coverage will hit low-income residents the hardest, worsening health disparities.
Studies show that GLP-1 therapies can lead to a >40% reduction in major cardiac events and 7% lower medical costs by year two (AON Study, 2025).
NC Residents: Email or call your House and Senate representatives and tell them to protect Medicaid access to anti-obesity care.
Help inform the public before it’s too late. This issue affects real families, healthcare workers, and our state’s future health costs.
North Carolina Obesity Society
info@ncobesitysociety.org
ncobesitysociety.org
Dr. Stephanie Page, board member of NC Obesity Society
Shares powerful insights from years of patient care – and why continued Medicaid coverage for GLP-1 medications is essential for health equity and long-term savings.
Over 600,000 North Carolinians rely on Medicaid. Cutting access to proven obesity treatments would be devastating – especially in rural and underserved communities.
Read her compelling op-ed and learn why this isn’t just a policy decision – it’s a matter of public health, fairness, and compassion